Over the forecast period, the pharmaceutical and biotechnology firms segment is expected to grow. The unexpected COVID-19 outbreak raised the demand for biologics to treat affected persons and offer immunizations. Because of novel medication discovery and protein pharmaceutical synthesis employing recombinant DNA technology, the pharmaceutical and biotechnology segments are likely to hold the majority of the market during the projection period. Key factors such as increased research & development spending by the pharmaceutical and biotechnology sectors to develop protein-based therapy are projected to significantly impact market growth.
Access full Report @ https://www.databridgemarketresearch.com/ko/reports/global-pharmaceutical-isolator-market
Data Bridge Market Research analyses that the Pharmaceutical Isolator Market will grow at a CAGR of 14.30% in the forecast period of 2022 to 2029 and is expected to reach USD 6,297.27 million by 2029 from USD 2,161.63 million in 2021. Pharmaceutical isolators help to create a sterile environment for the manufacturing of drugs, which is essential for ensuring the safety and efficacy of these products. Biopharmaceuticals are complex drugs that are often manufactured using living cells. Pharmaceutical isolators can help protect these cells from contamination, which is essential for producing high-quality biopharmaceuticals. Regulatory bodies worldwide increasingly require pharmaceutical companies to use pharmaceutical isolators in their manufacturing processes. This is due to the growing concern about the safety of drug manufacturing and the need to ensure that drugs are produced in a controlled environment.
Growing demand for safe and effective drug manufacturing is expected to drive the market's growth rate
The pharmaceutical industry is under increasing pressure to produce safe and effective drugs. Pharmaceutical isolators can help to create a sterile environment for the manufacturing of drugs, which is essential for ensuring the safety and efficacy of these products. Biopharmaceuticals are complex drugs that are often manufactured using living cells. Pharmaceutical isolators can help protect these cells from contamination, which is essential for producing high-quality biopharmaceuticals. Regulatory bodies worldwide increasingly require pharmaceutical companies to use pharmaceutical isolators in their manufacturing processes. This is due to the growing concern about the safety of drug manufacturing and the need to ensure that drugs are produced in a controlled environment.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014- 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling And Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Radiopharmaceutical Isolators, Production Isolators, Others), System Type (Closed System, Open System), Pressure (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Modular, Mobile, Compact, Table Top, Portable, Others), Application (Sterility Testing, Manufacturing, Sampling/ Weighing/ Distribution, Medical Device Manufacturing), End User (Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Getinge (Sweden), SKAN AG (Switzerland), Hosokawa micron ltd (India), Gelman Singapore (India), Azbil Corporation (Japan), Germfree Laboratories, Inc. (U.S.), MBRAUN (Germany), Nuaire (U.S.), Iteco S.R.L. (Italy), COMECER S.p.A. (Italy), Hecht Technologie Gmbh (Germany), Steriline S.R.L. (Italy), Envair Electrodyne (India), Tema Sinergie S.P.A (Italy), Schematic Engineering Industries (India), Chiyoda Corporation (Japan), Bioquell (U.S.), Jacomex (France), Fedegari Autoclavi S.p.A. (Italy), LAF Technologies (Australia), ISO Tech Design (Canada), Cytiva (U.S.), Esco Pharma (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The global pharmaceutical isolator market is segmented based on by type, pressure, application, configuration, system type, end user, and distribution channel.
- On the basis of type, the global pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators, others. Aseptic isolators is expected to dominate the global pharmaceutical isolator market with a market share of 28.82% due to rising demand of pharmaceutical industries and manufacturing of drugs.
- On the basis of system type, the global pharmaceutical isolator market is segmented into closed system and open system. Closed system is expected to dominate the global pharmaceutical isolator market with a market share of 63.08% due to rising healthcare expenditure and increase in research and development work to produce innovative treatments.
- On the basis of pressure, the global pharmaceutical isolator market is segmented into positive pressure and negative pressure. Positive pressure is expected to dominate the global pharmaceutical isolator market with a market share of 64.84% due to increasing use of sterilized procedures.
- On the basis of configuration, the global pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, table top, portable, others. Floor standing is expected to dominate the global pharmaceutical isolator market with a market share of 27.37% due to increased strategic collaboration between key market players.
- On the basis of application, the global pharmaceutical isolator market is segmented into sterility testing, manufacturing , sampling/ weighing/ distribution, medical device manufacturing, others. Sterility testing is expected to dominate the global pharmaceutical isolator market with a market share of 57.16% due to rising use of isolators in pharmaceutical & medical device industries.
- On the basis of end user, the global pharmaceutical isolator market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, others. Hospitals is expected to dominate the global pharmaceutical isolator market with a market share of 39.89% due to rising use of isolators in hospital pharmacies.
The hospitals segment will dominate the end user segment of the pharmaceutical isolator market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of distribution channel, the global pharmaceutical isolator market is segmented into direct tender, retail sales, third party distributors. Direct tender is expected to dominate the global pharmaceutical isolator market with a market share of 47.16% due to rise in production of pharmaceutical isolators in the market.
The direct tender segment will dominate the distribution channel segment of the pharmaceutical isolator market
The direct tender segment will emerge as the dominating segment under distribution channel. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Getinge (Sweden), SKAN AG (Switzerland), Hosokawa micron ltd (India), Gelman Singapore (India), Azbil Corporation (Japan), Germfree Laboratories, Inc. (U.S.), MBRAUN (Germany), Nuaire (U.S.), Iteco S.R.L. (Italy), COMECER S.p.A. (Italy), Hecht Technologie Gmbh (Germany), Steriline S.R.L. (Italy), Envair Electrodyne (India), Tema Sinergie S.P.A (Italy), Schematic Engineering Industries (India), Chiyoda Corporation (Japan), Bioquell (U.S.), Jacomex (France), Fedegari Autoclavi S.p.A. (Italy), LAF Technologies (Australia), ISO Tech Design (Canada), Cytiva (U.S.), Esco Pharma (U.S.).
Market Development
- In 2021, BICO, a global leader in cell-based therapies, signed a two-year deal with Applitech Pharmaceutical Equipment Technology to distribute its single-cell isolators in China. The deal, worth more than USD 10 million, will see nearly 100 of BICO's single-cell isolators distributed to Applitech's customers in China. The deal with Applitech is a major win for BICO. It will help the company to expand its reach in China, which is one of the world's largest and fastest-growing pharmaceutical markets. The deal is also a sign of the growing demand for cell-based therapies.
- In 2021, ILC Dover, a leading manufacturer of containment products, launched the flexible aseptic isolator for pharma and biopharma. The isolator is designed to provide a safe and controlled environment for the manufacturing of biopharmaceutical products. The flexible aseptic isolator is made from a single-use, flexible material that is easy to install and maintain. It is also designed to be scalable, so it can be used to manufacture a variety of biopharmaceutical products. The launch of the flexible aseptic isolator is a significant development for ILC Dover. It is the company's first product specifically designed for the biopharmaceutical market. The isolator is expected to help ILC Dover to grow its business in this rapidly growing market.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the pharmaceutical isolator market during the forecast period 2022-2029
North America is the largest market for pharmaceutical isolators. The region is expected to continue to dominate the market during the forecast period, owing to the presence of a large number of pharmaceutical companies and the high regulatory requirements for drug manufacturing. The United States is North America's largest market for pharmaceutical isolators, followed by Canada.
Asia-Pacific is estimated to be the fastest-growing region in the pharmaceutical isolator market in the forecast period 2022-2029
Asia-Pacific is expected to be the fastest-growing market for pharmaceutical isolators. The growth of the market in Asia-Pacific is attributed to the rising demand for biopharmaceuticals, the increasing investment in the pharmaceutical industry, and the growing regulatory requirements for drug manufacturing. China, India, and Japan are the leading markets for pharmaceutical isolators in Asia-Pacific.
For more detailed information about the pharmaceutical isolator market report, click here – https://www.databridgemarketresearch.com/ko/reports/global-pharmaceutical-isolator-market
